AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
4.580
+0.310 (7.26%)
At close: Aug 13, 2025, 4:00 PM
4.425
-0.155 (-3.38%)
Pre-market: Aug 14, 2025, 9:21 AM EDT
AbCellera Biologics Market Cap
AbCellera Biologics has a market cap or net worth of $1.37 billion as of August 14, 2025. Its market cap has increased by 44.10% in one year.
Market Cap
1.37B
Enterprise Value
957.66M
1-Year Change
44.10%
Ranking
Category
Stock Price
$4.58
Market Cap Chart
Since the IPO on December 11, 2020, AbCellera Biologics's market cap has decreased from $15.66B to $1.37B, a decrease of -91.26%. That is a compound annual growth rate of -40.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.37B | 57.98% |
| Dec 31, 2024 | 865.42M | -47.77% |
| Dec 29, 2023 | 1.66B | -42.83% |
| Dec 30, 2022 | 2.90B | -28.02% |
| Dec 31, 2021 | 4.03B | -62.83% |
| Dec 31, 2020 | 10.83B | -30.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |